JP2019533803A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533803A5
JP2019533803A5 JP2019508235A JP2019508235A JP2019533803A5 JP 2019533803 A5 JP2019533803 A5 JP 2019533803A5 JP 2019508235 A JP2019508235 A JP 2019508235A JP 2019508235 A JP2019508235 A JP 2019508235A JP 2019533803 A5 JP2019533803 A5 JP 2019533803A5
Authority
JP
Japan
Prior art keywords
capsid
aav
particles
amino acid
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019508235A
Other languages
English (en)
Japanese (ja)
Other versions
JP7021191B2 (ja
JP2019533803A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/046814 external-priority patent/WO2018035059A1/en
Publication of JP2019533803A publication Critical patent/JP2019533803A/ja
Publication of JP2019533803A5 publication Critical patent/JP2019533803A5/ja
Priority to JP2022014629A priority Critical patent/JP2022064980A/ja
Application granted granted Critical
Publication of JP7021191B2 publication Critical patent/JP7021191B2/ja
Priority to JP2023202414A priority patent/JP2024023460A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019508235A 2016-08-15 2017-08-14 Aavを検出するための方法 Active JP7021191B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022014629A JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法
JP2023202414A JP2024023460A (ja) 2016-08-15 2023-11-30 Aavを検出するための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662375314P 2016-08-15 2016-08-15
US62/375,314 2016-08-15
PCT/US2017/046814 WO2018035059A1 (en) 2016-08-15 2017-08-14 Methods for detecting aav

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022014629A Division JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法

Publications (3)

Publication Number Publication Date
JP2019533803A JP2019533803A (ja) 2019-11-21
JP2019533803A5 true JP2019533803A5 (https=) 2020-09-24
JP7021191B2 JP7021191B2 (ja) 2022-02-16

Family

ID=59762045

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019508235A Active JP7021191B2 (ja) 2016-08-15 2017-08-14 Aavを検出するための方法
JP2022014629A Pending JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法
JP2023202414A Pending JP2024023460A (ja) 2016-08-15 2023-11-30 Aavを検出するための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022014629A Pending JP2022064980A (ja) 2016-08-15 2022-02-02 Aavを検出するための方法
JP2023202414A Pending JP2024023460A (ja) 2016-08-15 2023-11-30 Aavを検出するための方法

Country Status (23)

Country Link
US (5) US11698377B2 (https=)
EP (2) EP3851449A1 (https=)
JP (3) JP7021191B2 (https=)
KR (5) KR102538037B1 (https=)
CN (2) CN118688363A (https=)
AU (2) AU2017312951B2 (https=)
CA (1) CA3033856A1 (https=)
CL (2) CL2019000392A1 (https=)
CR (1) CR20190127A (https=)
CY (1) CY1124364T1 (https=)
DK (1) DK3497207T3 (https=)
ES (1) ES2863674T3 (https=)
HU (1) HUE053747T2 (https=)
IL (3) IL264819B2 (https=)
MA (1) MA55748A (https=)
MX (2) MX2019001938A (https=)
NZ (3) NZ791267A (https=)
PH (1) PH12019500316A1 (https=)
SG (2) SG11201901221YA (https=)
TN (1) TN2019000047A1 (https=)
TW (2) TWI781953B (https=)
WO (1) WO2018035059A1 (https=)
ZA (2) ZA201900945B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201508026D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Capsid
NZ791267A (en) 2016-08-15 2025-11-28 Genzyme Corp Methods for detecting AAV
JP7455579B2 (ja) * 2017-02-28 2024-03-26 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 新規アデノ随伴ウイルス(aav)クレードfベクター及びその用途
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
IL276859B2 (en) * 2018-02-27 2025-12-01 Univ Pennsylvania Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor
MX2020008932A (es) * 2018-02-27 2020-10-01 Univ Pennsylvania Novedosos vectores de virus adenoasociado (aav), vectores de aav que tienen una desamidacion reducida de la capside y usos de estos.
WO2019173434A1 (en) * 2018-03-06 2019-09-12 Voyager Therapeutics, Inc. Insect cell manufactured partial self-complementary aav genomes
US11391707B2 (en) * 2018-07-27 2022-07-19 Waters Technologies Corporation Liquid chromatography/mass spectrometry methods for the analysis of polar molecules
EP3841109A4 (en) * 2018-08-21 2022-09-21 Massachusetts Eye and Ear Infirmary COMPOSITIONS AND METHODS TO MODULATE THE TRANSDUCTION EFFICIENCY OF ADENO-ASSOCIATED VIRUSES
US11345929B2 (en) * 2018-10-25 2022-05-31 Regeneron Pharmaceuticals, Inc. Methods for analysis of viral capsid protein composition
HUE064411T2 (hu) * 2019-04-11 2024-03-28 Regenxbio Inc Méretkizárásos kromatográfiás módszerek rekombináns adeno-asszociált víruskészítmények jellemzésére
US11841352B2 (en) * 2019-07-31 2023-12-12 Thermo Finnigan Llc Determination and correction of retention time and mass/charge shifts in LC-MS experiments
CA3165911A1 (en) * 2020-01-03 2021-07-08 Sarepta Therapeutics, Inc. Methods for analyzing aav capsid proteins
US20210261625A1 (en) 2020-01-29 2021-08-26 Genzyme Corporation Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof
CN111517359B (zh) * 2020-04-23 2021-08-20 江南大学 一种手性硫化铜超粒子的合成方法
RU2748540C1 (ru) * 2021-02-08 2021-05-26 Автономная некоммерческая образовательная организация высшего образования "Сколковский институт науки и технологий" Способ детектирования вируса SARS-CoV-2 методом масс-спектрометрии
WO2022175728A1 (en) * 2021-02-19 2022-08-25 Waters Technologies Corporation Methods for peptide mapping of adeno-associated virus (aav) proteins
EP4328292A1 (en) * 2021-04-20 2024-02-28 Universal Bio-Sampling Inc. Specimen retention card and specimen inspection method using same
TW202321691A (zh) * 2021-07-12 2023-06-01 美商再生元醫藥公司 用於分析病毒粒子之線上原生質譜方法
MX2024000133A (es) * 2021-07-12 2024-03-22 Regeneron Pharma Ensayo de cromatografía líquida para determinar la relación de la cápside de aav.
CN113552349B (zh) * 2021-07-30 2022-07-19 上海勉亦生物科技有限公司 Aav蛋白外壳的检测方法
JPWO2023132338A1 (https=) * 2022-01-06 2023-07-13
US20250110119A1 (en) * 2023-03-03 2025-04-03 Sartorius Bioanalytical Instruments, Inc. Methods for quantitating viral capsids
US20240418730A1 (en) * 2023-06-19 2024-12-19 Regeneron Pharmaceuticals, Inc. Host cell protein analysis for adeno-associated virus (aav)-based gene therapy
US20250145969A1 (en) * 2023-11-08 2025-05-08 Oxford Biomedica (Us) Llc Deamidation Depleted Adeno-Associated Virus Product

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540931A (en) 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US6204059B1 (en) * 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
AU722624B2 (en) 1996-09-06 2000-08-10 Trustees Of The University Of Pennsylvania, The An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6995006B2 (en) 1997-09-05 2006-02-07 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
PT1916258E (pt) 1999-08-09 2014-07-29 Genzyme Corp Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
NZ522840A (en) 2000-06-01 2004-12-24 Univ North Carolina A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
NZ532635A (en) 2001-11-13 2007-05-31 Univ Pennsylvania A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
WO2004027019A2 (en) 2002-05-01 2004-04-01 University Of Florida Research Foundation, Inc. Improved raav expression systems for genetic modification of specific capsid proteins
CA2503292A1 (en) * 2002-11-22 2004-06-10 Caprion Pharmaceuticals, Inc. Constellation mapping and uses thereof
WO2004075861A2 (en) 2003-02-26 2004-09-10 Children's Hospital, Inc. Recombinant adeno-associated virus production
DE602004030327D1 (de) 2003-05-21 2011-01-13 Genzyme Corp Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind
EP1486567A1 (en) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved adeno-associated virus (AAV) vector for gene therapy
US9441244B2 (en) * 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US8283151B2 (en) 2005-04-29 2012-10-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
EP2311967B1 (en) * 2005-10-20 2017-09-20 UniQure IP B.V. Improved AAV vectors produced in insect cells
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
WO2010031865A1 (en) 2008-09-19 2010-03-25 Charitē Universitätsmedizin Berlin Identification and characterisation of recombinant viral gene therapy vectors
EP2396343B1 (en) 2009-02-11 2017-05-17 The University of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
HUE028341T2 (en) 2009-06-16 2016-12-28 Genzyme Corp Improved methods for purification of recombinant aav vectors
EP2826860B1 (en) 2010-04-23 2018-08-22 University of Massachusetts CNS targeting AAV vectors and methods of use thereof
US20130217789A1 (en) * 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
US8663624B2 (en) 2010-10-06 2014-03-04 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
DK2675902T3 (da) 2011-02-17 2019-06-03 Univ Pennsylvania Sammensætninger og fremgangsmåder til at ændre vævsspecificitet og forbedre aav9-medieret genoverførsel
ES2857773T5 (es) 2011-08-24 2024-06-04 Univ Leland Stanford Junior Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
AU2013249202B2 (en) 2012-04-18 2018-08-09 The Children's Hospital Of Philadelphia Composition and methods for highly efficient gene transfer using AAV capsid variants
US20140017716A1 (en) * 2012-07-11 2014-01-16 Siscapa Assay Technologies, Inc. Proteolytic digestion kit with dried reagents
GB201401707D0 (en) * 2014-01-31 2014-03-19 Sec Dep For Health The Adeno-associated viral vectors
WO2015137802A1 (en) * 2014-03-10 2015-09-17 Uniqure Ip B.V. Further improved aav vectors produced in insect cells
NZ791267A (en) 2016-08-15 2025-11-28 Genzyme Corp Methods for detecting AAV

Similar Documents

Publication Publication Date Title
JP2019533803A5 (https=)
KR102604510B1 (ko) 신규 아데노-관련 바이러스 캡시드 단백질
JP2021516046A5 (https=)
JP7698624B2 (ja) 空のおよび完全なウイルスキャプシド粒子の分離および定量化
ES2580044T3 (es) Método de incremento de la función de un vector de AAV
CN105636981B (zh) 腺相关病毒因子viii载体
CN113874385A (zh) 突变的腺相关病毒衣壳蛋白、包含该蛋白的aav颗粒和肝定向aav载体基因治疗
JP2017509632A5 (https=)
HRP20192141T1 (hr) Genska terapija za retinitis pigmentosa
EP4172322A1 (en) Improved adeno-associated virus gene therapy vectors
JP2024102283A (ja) 組換えアデノ随伴ウイルス組成物の特性評価のためのサイズ排除クロマトグラフィーの方法
Sorroza-Martinez et al. Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung Diseases
JPWO2020168222A5 (https=)
US20240271160A1 (en) Production of adeno-associated virus vector in insect cells
EP4644556A1 (en) Method for producing adeno-associated virus, and vector set
RU2022110175A (ru) Способы выявления aav
RU2019107207A (ru) Cпособы выявления aav
US20260028598A1 (en) Method for separating full and empty AAV particles
JPWO2021221995A5 (https=)
WO2025228321A1 (en) METHOD OF SEPARATING RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV) PARTICLES
TW202600829A (zh) 重組核酸分子、包括其的載體和宿主細胞、其用途及生產重組aav的方法
WO2025207456A1 (en) Methods for purification of adeno associated virus particles by anion exchange chromatography
HK40119481A (zh) 用於分离完整的aav颗粒和空aav颗粒的方法
CN117836421A (zh) 在昆虫细胞中制备腺相关病毒载体
RU2779318C2 (ru) Новые капсидные белки адено-ассоциированного вируса